Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress
- Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug
- Why Some Monkeys Don't Get AIDS
- Potential For Creating Less Toxic Anti-HIV Drugs Following Discovery Of Enzyme Structure
- ASGT 12th Annual Meeting: Gene Therapy Controls HIV, Research Shows
- Monkey Control Of SIV Infection Provides Insight Into HIV
- Also In Global Health News: Indonesia To Host AIDS Congress; Smoking Ban In Ghana
- New Survey Targets Over 50s Living With HIV, UK
- UNAIDS, NGOs Partner To Eliminate Mother-To-Child Transmission Of HIV In Africa
- Scientists Receive Grant To Develop Hand-Held Self-Monitoring Test For HIV Viral Loads
Prescription AIDS Drugs
Contact Us
U.S. Pharmaceutical Companies Developing 97 New Drugs And Vaccines To Fight HIV/AIDS
March 20th, 2010
Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development for HIV/AIDS and related conditions.
The report found that the 97 products in development include 23 vaccines and 54 antivirals. These drugs are either in human clinical trials or awaiting approval by the U.S. Food and Drug Administration (FDA).
“We are greatly encouraged by these critically important medicines and vaccines in development to treat and prevent HIV infection,” said PhRMA President and CEO Billy Tauzin. “Pharmaceutical researchers are continuing their efforts to develop new therapies and vaccines to improve and lengthen the lives of HIV-infected patients.”
“As a result of HIV/AIDS medicines, a disease that was once a virtual death sentence can now be controlled and treated as if it were a chronic disease,” stated Tauzin. “And the new medicines our scientists are working on right now bring hope for even more promising results in the future.”
December 1 marks the 21st anniversary of “World AIDS Day” - a global awareness campaign that originated at the 1988 World Summit of Ministers of Health on Programmes for AIDS Prevention.
Source: Pharmaceutical Research and Manufacturers of America
Related posts:
- New Report Shows 97 Medicines And Vaccines Currently In Development For HIV/AIDS America’s pharmaceutical research and biotechnology companies are testing 97 medicines...
- Brazil Proves Developing Countries Can Use Generic Medicines To Fight HIV/AIDS Epidemic Brazil’s nearly two-decade effort to treat people living with HIV...
- Drug Companies Called On To Pool HIV Patents The international medical humanitarian organization Doctors Without Borders/Medecins Sans Frontières...
- Ohr Pharmaceutical Data Review Supports The Strong Potential Of Its Lead Drug OHR/AVR118 For Cachexia Ohr Pharmaceutical Inc. (OTCBB: OHRP) is developing OHR/AVR118 for treatment...
- U.S. Must Do More To Address Maternal Mortality In Developing Countries, Rep. Moore Writes In Opinion Piece President Obama and first lady Michelle Obama’s visit to Africa...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.